Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention

Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly( d,l-lactic-co-glycolic)acid (PLGA) microspheres using t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2002-06, Vol.81 (3), p.307-319
Hauptverfasser: Castellanos, Ingrid J., Cruz, Gloydian, Crespo, Rubén, Griebenow, Kai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 319
container_issue 3
container_start_page 307
container_title Journal of controlled release
container_volume 81
creator Castellanos, Ingrid J.
Cruz, Gloydian
Crespo, Rubén
Griebenow, Kai
description Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly( d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.
doi_str_mv 10.1016/S0168-3659(02)00073-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71778124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365902000731</els_id><sourcerecordid>71778124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</originalsourceid><addsrcrecordid>eNqFkM9O3DAQhy1UVLbQR6DKpag9BDxxYjsnhFbbFgmJA_Ray2uPF6NsEuxkpTxX34NnqvePypGLPWN9P3v8EXIO9BIo8KuHtMic8ar-RovvlFLBcjgiM5CpKOu6-kBm_5ET8inG5wRVrBQfyQkUtCwrXs_In0VrdB_HRg--a3Pf2tGgzfRqFXC1O8t0a7OmizHzqTaD3_hhyjqXvf7NzdO07oYw9dHvueEJfcj6gBtst-Ezcux0E_HzYT8lv38sHue_8rv7n7fzm7vcsBqGnNmy4JKDYUWtKTOVrSvQyKiUjovUL4UGyYuSO1Y4W1K3dAwlF4BLKyVlp-Rif28fupcR46DWPhpsGt1iN0YlQAgJRZnAag-akL4U0Kk--LUOkwKqtmLVTqzaWlO0UDuxClLuy-GBcblG-5Y6mEzA1wOgo9GNC7o1Pr5xTEAtQSTues9h0rHxGFQ0Htsk3Qc0g7Kdf2eUf4ylllo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71778124</pqid></control><display><type>article</type><title>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Castellanos, Ingrid J. ; Cruz, Gloydian ; Crespo, Rubén ; Griebenow, Kai</creator><creatorcontrib>Castellanos, Ingrid J. ; Cruz, Gloydian ; Crespo, Rubén ; Griebenow, Kai</creatorcontrib><description>Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly( d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/S0168-3659(02)00073-1</identifier><identifier>PMID: 12044569</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Biological and medical sciences ; Chymotrypsin - chemistry ; Drug Stability ; Excipients ; Excipients - chemistry ; General pharmacology ; Lactic Acid - chemistry ; Medical sciences ; Microencapsulation ; Microspheres ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polyethylene Glycols - chemistry ; Polyglycolic Acid - chemistry ; Polymers - chemistry ; Protein aggregation ; Protein stabilization ; Protein Structure, Secondary ; Solid-in-oil-in-water (s/o/w) encapsulation procedure ; Trehalose - chemistry</subject><ispartof>Journal of controlled release, 2002-06, Vol.81 (3), p.307-319</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</citedby><cites>FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0168-3659(02)00073-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13719817$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12044569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castellanos, Ingrid J.</creatorcontrib><creatorcontrib>Cruz, Gloydian</creatorcontrib><creatorcontrib>Crespo, Rubén</creatorcontrib><creatorcontrib>Griebenow, Kai</creatorcontrib><title>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly( d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.</description><subject>Biological and medical sciences</subject><subject>Chymotrypsin - chemistry</subject><subject>Drug Stability</subject><subject>Excipients</subject><subject>Excipients - chemistry</subject><subject>General pharmacology</subject><subject>Lactic Acid - chemistry</subject><subject>Medical sciences</subject><subject>Microencapsulation</subject><subject>Microspheres</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Polyglycolic Acid - chemistry</subject><subject>Polymers - chemistry</subject><subject>Protein aggregation</subject><subject>Protein stabilization</subject><subject>Protein Structure, Secondary</subject><subject>Solid-in-oil-in-water (s/o/w) encapsulation procedure</subject><subject>Trehalose - chemistry</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM9O3DAQhy1UVLbQR6DKpag9BDxxYjsnhFbbFgmJA_Ray2uPF6NsEuxkpTxX34NnqvePypGLPWN9P3v8EXIO9BIo8KuHtMic8ar-RovvlFLBcjgiM5CpKOu6-kBm_5ET8inG5wRVrBQfyQkUtCwrXs_In0VrdB_HRg--a3Pf2tGgzfRqFXC1O8t0a7OmizHzqTaD3_hhyjqXvf7NzdO07oYw9dHvueEJfcj6gBtst-Ezcux0E_HzYT8lv38sHue_8rv7n7fzm7vcsBqGnNmy4JKDYUWtKTOVrSvQyKiUjovUL4UGyYuSO1Y4W1K3dAwlF4BLKyVlp-Rif28fupcR46DWPhpsGt1iN0YlQAgJRZnAag-akL4U0Kk--LUOkwKqtmLVTqzaWlO0UDuxClLuy-GBcblG-5Y6mEzA1wOgo9GNC7o1Pr5xTEAtQSTues9h0rHxGFQ0Htsk3Qc0g7Kdf2eUf4ylllo</recordid><startdate>20020617</startdate><enddate>20020617</enddate><creator>Castellanos, Ingrid J.</creator><creator>Cruz, Gloydian</creator><creator>Crespo, Rubén</creator><creator>Griebenow, Kai</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020617</creationdate><title>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</title><author>Castellanos, Ingrid J. ; Cruz, Gloydian ; Crespo, Rubén ; Griebenow, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Chymotrypsin - chemistry</topic><topic>Drug Stability</topic><topic>Excipients</topic><topic>Excipients - chemistry</topic><topic>General pharmacology</topic><topic>Lactic Acid - chemistry</topic><topic>Medical sciences</topic><topic>Microencapsulation</topic><topic>Microspheres</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Polyglycolic Acid - chemistry</topic><topic>Polymers - chemistry</topic><topic>Protein aggregation</topic><topic>Protein stabilization</topic><topic>Protein Structure, Secondary</topic><topic>Solid-in-oil-in-water (s/o/w) encapsulation procedure</topic><topic>Trehalose - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castellanos, Ingrid J.</creatorcontrib><creatorcontrib>Cruz, Gloydian</creatorcontrib><creatorcontrib>Crespo, Rubén</creatorcontrib><creatorcontrib>Griebenow, Kai</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castellanos, Ingrid J.</au><au>Cruz, Gloydian</au><au>Crespo, Rubén</au><au>Griebenow, Kai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2002-06-17</date><risdate>2002</risdate><volume>81</volume><issue>3</issue><spage>307</spage><epage>319</epage><pages>307-319</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly( d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>12044569</pmid><doi>10.1016/S0168-3659(02)00073-1</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2002-06, Vol.81 (3), p.307-319
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_71778124
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Chymotrypsin - chemistry
Drug Stability
Excipients
Excipients - chemistry
General pharmacology
Lactic Acid - chemistry
Medical sciences
Microencapsulation
Microspheres
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polyethylene Glycols - chemistry
Polyglycolic Acid - chemistry
Polymers - chemistry
Protein aggregation
Protein stabilization
Protein Structure, Secondary
Solid-in-oil-in-water (s/o/w) encapsulation procedure
Trehalose - chemistry
title Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A20%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Encapsulation-induced%20aggregation%20and%20loss%20in%20activity%20of%20%CE%B3-chymotrypsin%20and%20their%20prevention&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Castellanos,%20Ingrid%20J.&rft.date=2002-06-17&rft.volume=81&rft.issue=3&rft.spage=307&rft.epage=319&rft.pages=307-319&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/S0168-3659(02)00073-1&rft_dat=%3Cproquest_cross%3E71778124%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71778124&rft_id=info:pmid/12044569&rft_els_id=S0168365902000731&rfr_iscdi=true